首页> 美国卫生研究院文献>Journal of Histochemistry and Cytochemistry >Quantitative Imaging of Preamyloid Oligomers a Novel Structural Abnormality in Human Atrial Samples
【2h】

Quantitative Imaging of Preamyloid Oligomers a Novel Structural Abnormality in Human Atrial Samples

机译:前房淀粉样低聚物一种新型的结构异常在人类心房样本中的定​​量成像。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abnormalities in atrial myocardium increase the likelihood of arrhythmias, including atrial fibrillation (AF). The deposition of misfolded protein, or amyloidosis, plays an important role in the pathophysiology of many diseases, including human cardiomyopathies. We have shown that genes implicated in amyloidosis are activated in a cellular model of AF, with the development of preamyloid oligomers (PAOs). PAOs are intermediates in the formation of amyloid fibrils, and they are now recognized to be the cytotoxic species during amyloidosis. To investigate the presence of PAOs in human atrium, we developed a microscopic imaging-based protocol to enable robust and reproducible quantitative analysis of PAO burden in atrial samples harvested at the time of elective cardiac surgery. Using PAO- and myocardial-specific antibodies, we found that PAO distribution was typically heterogeneous within a myocardial sample. Rigorous imaging and analysis protocols were developed to quantify the relative area of myocardium containing PAOs, termed the Green/Red ratio (G/R), for a given sample. Using these methods, reproducible G/R values were obtained when different sections of a sample were independently processed, imaged, and analyzed by different investigators. This robust technique will enable studies to investigate the role of this novel structural abnormality in the pathophysiology of and arrhythmia generation in human atrial tissue.
机译:心房心肌异常增加了心律不齐的可能性,包括心房纤颤(AF)。折叠错误的蛋白质或淀粉样变性病的沉积,在包括人类心肌病在内的许多疾病的病理生理中起着重要作用。我们已经表明,与淀粉样变性有关的基因在房颤的细胞模型中被激活,伴随着淀粉样前低聚物(PAOs)的发展。 PAO是淀粉样蛋白原纤维形成过程中的中间体,现在人们公认它们是淀粉样变性过程中的细胞毒性物质。为了调查人心房中PAO的存在,我们开发了一种基于显微成像的协议,能够对心脏选择性手术时采集的心房样品中的PAO负担进行可靠且可重复的定量分析。使用PAO和心肌特异性抗体,我们发现PAO分布在心肌样本中通常是异质的。开发了严格的成像和分析方案来量化给定样品的含心肌的PAO的相对面积,称为绿色/红色比(G / R)。使用这些方法,当样品的不同部分由不同的研究人员独立处理,成像和分析时,可获得可重复的G / R值。这项强大的技术将使研究能够研究这种新型结构异常在人类心房组织的病理生理和心律失常中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号